Fatty acid binding protein 4 as a biomarker for improvement of type 2 diabetes

被引：0
|
作者：
Mehra, R. [1 ]
Stentz, F. [1 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2023年 / 365卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
140
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Fatty Acid-Binding Protein 4 as a Biomarker for Remission of Type 2 Diabetes
    Stentz, Frankie B.
    DIABETES, 2023, 72
  • [2] Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
    Shaker, Amr M.
    Mohamed, Maggie E.
    Ramzy, Tarek
    Ali, Mayssa I.
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01):
  • [3] Serum fatty acid-binding protein 4 as a biomarker for early detection of diabetic nephropathy in type 2 diabetes
    Amr M. Shaker
    Maggie E. Mohamed
    Tarek Ramzy
    Mayssa I. Ali
    The Egyptian Journal of Internal Medicine, 35
  • [4] Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes
    Rodriguez-Calvo, Ricardo
    Girona, Josefa
    Rodriguez, Marina
    Samino, Sara
    Barroso, Emma
    de Gonzalo-Calvo, David
    Guaita-Esteruelas, Sandra
    Heras, Mercedes
    van der Meer, Rutger W.
    Lamb, Hildo J.
    Yanes, Oscar
    Correig, Xavier
    Llorente-Cortes, Vicenta
    Vazquez-Carrera, Manuel
    Masana, Lluis
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 96 : 12 - 21
  • [5] Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes
    Wang, Yifeng
    Ding, Licheng
    Yang, Jiayue
    Liu, Lijun
    Dong, Liang
    PEERJ, 2021, 9
  • [6] Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes
    Aragones, Gemma
    Ferre, Raimon
    Lazaro, Iolanda
    Cabre, Anna
    Plana, Nuria
    Merino, Jordi
    Heras, Mercedes
    Girona, Josefa
    Masana, Lluis
    ATHEROSCLEROSIS, 2010, 213 (01) : 329 - 331
  • [7] Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes
    Bu, Liming
    Salto, Lorena M.
    De Leon, Kevin J.
    De Leon, Marino
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (01) : 82 - 91
  • [8] The polymorphisms in the promoter region of fatty acid binding protein 2 are associated with Type 2 diabetes
    Li, Y
    Fisher, E
    Boeing, H
    Möhlig, M
    Burwinkel, B
    Schrezenmeir, J
    DIABETOLOGIA, 2004, 47 : A135 - A135
  • [9] Urinary fatty acid-binding protein 4 is a promising biomarker for glomerular damage in patients with diabetes mellitus
    Tanaka, Marenao
    Sato, Tatsuya
    Gohda, Tomohito
    Kamei, Nozomu
    Murakoshi, Maki
    Ishiwata, Erika
    Endo, Keisuke
    Kawaharata, Wataru
    Aida, Hiroki
    Nakata, Kei
    Akiyama, Yukinori
    Kubota, Mitsunobu
    Sanuki, Michiyoshi
    Suzuki, Toru
    Suzuki, Yusuke
    Furuhashi, Masato
    JOURNAL OF DIABETES INVESTIGATION, 2024,
  • [10] Fatty acid-binding protein-4 as a biomarker predicting acromegaly-associated diabetes mellitus
    Hepsen, Sema
    Akhanli, Pinar
    Duger, Hakan
    Calapkulu, Murat
    Ucan, Bekir
    Sencar, Muhammed Erkam
    Sakiz, Davut
    Unsal, Ilknur Ozturk
    Bayram, Seyit Murat
    Ozbek, Mustafa
    Cakal, Erman
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (05) : 2592 - 2599
12345